Novartis
Head Global Evidence Generation leads the end-to-end strategy for Integrated Evidence Plans across the product lifecycle, focusing on Phase IV studies, non-interventional and real-world evidence programmes, and driving innovation through AI and technology.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
Novartis didn’t post a salary, so this is our estimate from similar listings.
Director Evidence Generation
Diversity Employment
Director, Global Medical Evidence Generation Lead, Oncology
Bristol Myers Squibb
Evidence Generation Leadership
Ferring
Senior Director, Medical Evidence Generation, Immunology
Celldex Therapeutics
Medical Evidence Strategy Director
AstraZeneca
Evidence Generation Manager
Takeda Pharmaceutical Company Limited